Opinion
Video
A medical professional examines the pivotal roles of molecular profiling, next-generation sequencing, and germline testing in guiding treatment decisions for ovarian cancer.
Updated KRYSTAL-7 Data Show PFS Beyond 27 Months for Adagrasib Plus Pembro in First-line Treatment of KRAS-mutated NSCLC
Five Years Later: Ongoing COVID-19 Challenges, Next Steps
Prevalence, Severity of Astigmatism Increased in Children After Pandemic
Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi
PAH Therapies Improve Outcomes in PH-ILD
FDA Approves First New Class of Oral Antibiotics for Uncomplicated UTIs in Nearly 30 Years